Novel Presentation of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19

Abstract

Pediatric inflammatory multisystem syndrome temporally associated with coronavirus disease 2019 (COVID-19) is an emerging rare disease reported in children 4 to 6 weeks after a usually asymptomatic COVID-19 infection. Though it usually presents as a Kawasaki-like illness or toxic shock syndrome, other multisystem presentations have been reported. Presentation as hemiplegia, however, is rare. Here, we describe a child with acute hemiplegia and rapidly progressive shock, who responded dramatically to steroids and intravenous immunoglobulin and experienced a full recovery. By reporting this case, we wish to add to the literature this atypical presentation of this novel disease, and highlight the importance of quickly diagnosing and treating this life-threatening disease.

Keywords

PIMS-TS - COVID-19 - TIA - pediatric - stroke - hemiplegia

Publikationsverlauf

Eingereicht: 29. Dezember 2020

Angenommen: 28. Januar 2021

Artikel online veröffentlicht:
16. März 2021

• References

• 1 Whittaker E, Bamford A, Kenny J. et al; PIMS-TS Study Group and EUCLIDS and PERFORM Consortia. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020; 324 (03) 259-269
• 2 Chiotos K, Bassiri H, Behrens EM. et al. Multisystem inflammatory syndrome in children during the coronavirus 2019 pandemic: a case series. J Pediatric Infect Dis Soc 2020; 9 (03) 393-398
• 3 Jiang L, Tang K, Levin M. et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis 2020; 20 (11) e276-e288
• 4 Swann OV, Holden KA, Turtle L. et al; ISARIC4C Investigators. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ 2020; 370: m3249
• 5 Tiwari L, Shekhar S, Bansal A, Kumar S. COVID-19 associated arterial ischaemic stroke and multisystem inflammatory syndrome in children: a case report. Lancet Child Adolesc Health 2021; 5 (01) 88-90
• 6 Rauf A, Vijayan A, John ST, Krishnan R, Latheef A. Multisystem inflammatory syndrome with features of atypical Kawasaki disease during COVID-19 pandemic. Indian J Pediatr 2020; 87 (09) 745-747
• 7 Mukund B, Sharma M, Mehta A, Kumar A, Bhat V. Pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2–an emerging problem of PICU: a case series. J Pediatr Crit Care 2020; 7: 271-275
• 8 Royal College of Paediatrics and Child Health. ed. Guidance: Paediatric Multisystem Inflammatory Syndrome Temporally Associated with COVID-19. UK: Royal College of Paediatrics and Child Health. 2020
• 9 Centers for Disease Control and Prevention. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19). 2020 . Accessed July 20, 2020 at: https://emergency.cdc.gov/han/2020/han00432.asp
• 10 Guidance- COVID-19 paediatric multisystem inflammatory syndrome. Royal College of Paediatrics and Child Health. Accessed July 20, 2020 at: https://www.rcpch.ac.uk/resources/guidance-paediatricmultisystem-inflammatory-syndrome-temporally-associatedcovid-19
• 11 Ellul MA, Benjamin L, Singh B. et al. Neurological associations of COVID-19. Lancet Neurol 2020; 19 (09) 767-783
• 12 Paniz-Mondolfi A, Bryce C, Grimes Z. et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol 2020; 92 (07) 699-702